Skip to main content Deutsch

"An Exciting Journey" - MCCA PhD Symposium and SFB F46 Closing Event


26. August 2019
9:00 AM - 17:00 PM

Medizinische Universität Wien
Rektoratsgebäude (Bauteil 88), Ebene 2
Spitalgasse 23, 1090 Wien


An Exciting Journey

Molecular, Cellular and Clinical Allergology (MCCA) PhD Symposium and SFB F46 'Towards prevention and therapy of allergy' Closing Event on Mechanisms of IgE-associated Diseases and Novel Approaches for the Therapy of Allergy and Beyond


Molecular, Cellular and Clinical Allergology (MCCA) is a doctoral program of the Medical University of Vienna and the Veterinary University of Vienna, Austria.

SFB F46 'Towards prevention and therapy of allergy' is a special research program located at the Medical University of Vienna and the Karl-Franzens-University of Graz, Austria.

Both programs are funded by the FWF Austrian Science Fund.




08:30 - 09:00 Registration

09:00 - 09:15 Opening

  • Michaela Fritz, Vice Rector for Research and Innovation, Medical University of Vienna
  • Winfried Pickl, MCCA Speaker
  • Rudolf Valenta, SFB Speaker

09:15 - 10:10 Session One

  • Mohamed Ridha Barbouche, Institut Pasteur de Tunis, Tunisia: Molecular dissection of and IgE specificities behind hyper-IgE syndromes
  • Sonja Kopanja, Medical University of Vienna: Soluble FceRI disrupts cell-bound chimeric IgE

10:10 - 11:05 Session Two

  • Ted Jardetzky, Stanford University, California, USA: On the contribution of IgE-receptors to the pathology of allergy
  • Sergio Villazala, Medical University of Vienna: The crosslinking ability of IgE-allergen complexes and the concentrations of specific IgE determine the extent of T cell activation mediated by CD23-FAP

11:05 - 11:30 Coffee Break

11:30 - 12:25 Session Three

  • Alain Jacquet, Chulalongkorn University, Bangkok, Thailand: How house dust mite allergens target the adaptive and innate immune system
  • Tanja Kalic, Medical University of Vienna: The role of tropomyosin in cross-reactivity between house dust mite and shellfish

12:25 - 14:45 Lunch Break and Guided Poster Session

14:45 - 15:40 Session Four

  • Christopher Paige, Princess Margaret Cancer Centre, Toronto, Canada: Interleukin-12 based modulation of (tumor-)immunity
  • Natalia Alkon, Medical University of Vienna: Innate lymphoid cells (ILCs) in skin and blood

15:40 - 16:05 Coffee Break

16:05 - 17:00 Session Five

  • Torsten Tonn, Medical Faculty Carl Gustav Carus, TU Dresden, Germany: In vivo eradication of malignant and non-malignant (autoreactive, allergen-specific) cell types by CAR technology
  • Peter Tauber, Medical University of Vienna: The kinase inhibitor BX-795 is a TCR signaling modulator that stimulates IL-2 while attenuating Th2 responses

17:00 Closing Remarks




Free admission!

Please register online via